Literature DB >> 12435872

Autosomal dominant polycystic kidney disease - clinical and genetic aspects.

Nadja Bogdanova1, Arseni Markoff, Jürgen Horst.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common inherited disorders in humans. It accounts for 8-10% of the cases of end-stage renal disease worldwide, thus representing a serious medical, economical and social problem. ADPKD is in fact a systemic disorder, characterized with the development of cysts in the ductal organs (mainly the kidneys and the liver), also with gastrointestinal and cardiovascular abnormalities. In the last decade there was significant progress in uncovering the genetic foundations and in understanding of the pathogenic mechanisms leading to the renal impairment. This review will retrace the current knowledge about the epidemiology, pathogenesis, genetics, genetic and clinical heterogeneity, diagnostics and treatment of ADPKD. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12435872     DOI: 10.1159/000066788

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  3 in total

1.  Evaluation of zebrafish kidney function using a fluorescent clearance assay.

Authors:  Sonia Christou-Savina; Philip L Beales; Daniel P S Osborn
Journal:  J Vis Exp       Date:  2015-02-20       Impact factor: 1.355

2.  The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.

Authors:  Maria Wanic-Kossowska; Bartlomiej Posnik; Mikolaj Kobelski; Elzbieta Pawliczak; Krzysztof Pawlaczyk; Krzysztof Hoppe; Krzysztof Schwermer; Dorota Sikorska
Journal:  ScientificWorldJournal       Date:  2014-01-02

3.  Intestinal fistula accompanied by recurrent peritonitis associated with peritoneal dialysis: a case report.

Authors:  Qiuyuan Shao; Yangyang Xia; Qingyan Zhang; Miao Zhang
Journal:  BMC Gastroenterol       Date:  2020-05-24       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.